An official website of the United States government
September 29, 2026 Edition
News
Antiviral drug did not improve Long COVID symptoms
A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
News
tRNA treatment may help restore cystic fibrosis proteins
Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
News
Bacterial infection may alter developing gut
C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.
Displaying 281 - 287 of 912
Protein may be linked to exercise intolerance in ME/CFS
A study suggested that high levels of a protein may reduce energy production in the muscle cells of people with ME/CFS.
Chronic traumatic encephalopathy in young athletes
In a study of brains from contact sport players who died before reaching 30, more than 40% had chronic traumatic encephalopathy, or CTE.
Air pollution linked to dementia cases
Higher levels of a type of air pollution called PM2.5 were linked to a higher number of dementia cases developing over time.
Scientists translate brain activity into music
Researchers reconstructed a song based on the brain activity of people when they were listening to it.
Stroke patients may benefit from brain stimulation
In a small trial, deep brain stimulation plus physical therapy helped improve upper limb function in some patients who had impaired movement after a stroke.
Lizard tails give clues to cartilage formation
Scientists identified cells that play key roles in cartilage creation and the regrowth of severed tails in a small lizard. The findings may point to new avenues for repairing damaged cartilage in humans.
SARS-CoV-2 can cause lasting damage to cells' energy production
SARS-CoV-2, the virus that causes COVID-19, can cause lasting damage to energy production by mitochondria in many organs of the body.